Clinical and Molecular Assessment of Premature Ovarian Insufficiency: Biochemical Markers and NOBOX Gene Expression
ICME JOURNAL OF LABORATORY MEDICINE · 2026 · 7-15
DOI: 10.54646/icme.2026.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift ICME JOURNAL OF LABORATORY MEDICINE, 2026. Verfasst von Dinesh Roy Divakaran und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Premature ovarian Insufficiency (POI) significantly contributes to female infertility and involves both metabolic and genetic factors. This study assessed biochemical markers and NOBOX gene expression in women with POI to explore possible associations.
Aim
To evaluate the biochemical profile and NOBOX gene expression in POI and assess their potential link to infertility.
Methods
A case-control study was conducted at this research centre from December 2022 to December 2024. The study involved 120 women with clinically diagnosed POF and 120 age-matched fertile controls. Fasting blood sugar, total cholesterol, urea, and uric acid were measured using enzymatic assays. NOBOX gene expression was analysed using quantitative real-time PCR. ROC analysis was performed to assess the diagnostic value of the biochemical markers.
Results
Levels of fasting blood sugar, total cholesterol, urea, and uric acid were significantly elevated in POI cases compared to controls (p < 0.001). NOBOX gene expression was significantly lower in cases (p < 0.001). Among the biochemical parameters evaluated, fasting blood sugar showed the highest observed area under the receiver operating characteristic curve (AUC = 0.8036). At the sample-derived cut-off of 102.25 mg/dL, the sensitivity was 63% and the specificity was 93%, These findings represent exploratory discrimination between study cases and controls and require independent validation before clinical application. No significant correlation was observed between biochemical parameters and NOBOX expression.
Conclusion
This study identified differences in selected biochemical parameters and lower peripheral-blood NOBOX gene expression among women with premature ovarian insufficiency compared with fertile controls. No statistically significant correlations were detected between the measured biochemical parameters and NOBOX expression. These findings should be interpreted cautiously, as the study does not establish causality or demonstrate that the metabolic and molecular changes occur through independent pathways.
Zitieren
APA
Divakaran, D. R., Raveendran, P., Jose, S., Nair, J. J. S., G.B., R., & Sugunan, A. (2026). Clinical and Molecular Assessment of Premature Ovarian Insufficiency: Biochemical Markers and NOBOX Gene Expression. ICME JOURNAL OF LABORATORY MEDICINE, 7-15. https://doi.org/10.54646/icme.2026.19
Vancouver
Divakaran DR, Raveendran P, Jose S, Nair JJS, G.B. R, Sugunan A. Clinical and Molecular Assessment of Premature Ovarian Insufficiency: Biochemical Markers and NOBOX Gene Expression. ICME JOURNAL OF LABORATORY MEDICINE. 2026:7-15. doi:10.54646/icme.2026.19
BibTeX
@article{Divakaran2026,
author = {Divakaran, Dinesh Roy and Raveendran, Priya and Jose, Soumya and Nair, Jiju Jayasree Sasidharan and G.B., Ratheesh and Sugunan, Arun},
title = {Clinical and Molecular Assessment of Premature Ovarian Insufficiency: Biochemical Markers and NOBOX Gene Expression},
journal = {ICME JOURNAL OF LABORATORY MEDICINE},
year = {2026},
pages = {7--15},
doi = {10.54646/icme.2026.19}
}
EUVIMED